These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 11345220
1. Diagnostic evaluation of urinary lipoarabinomannan at an Ethiopian tuberculosis centre. Tessema TA, Hamasur B, Bjun G, Svenson S, Bjorvatn B. Scand J Infect Dis; 2001; 33(4):279-84. PubMed ID: 11345220 [Abstract] [Full Text] [Related]
3. Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Boehme C, Molokova E, Minja F, Geis S, Loscher T, Maboko L, Koulchin V, Hoelscher M. Trans R Soc Trop Med Hyg; 2005 Dec; 99(12):893-900. PubMed ID: 16139316 [Abstract] [Full Text] [Related]
4. Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients. Mutetwa R, Boehme C, Dimairo M, Bandason T, Munyati SS, Mangwanya D, Mungofa S, Butterworth AE, Mason PR, Corbett EL. Int J Tuberc Lung Dis; 2009 Oct; 13(10):1253-9. PubMed ID: 19793430 [Abstract] [Full Text] [Related]
5. Diagnostic accuracy of a urine lipoarabinomannan enzyme-linked immunosorbent assay for screening ambulatory HIV-infected persons for tuberculosis. Gounder CR, Kufa T, Wada NI, Mngomezulu V, Charalambous S, Hanifa Y, Fielding K, Grant A, Dorman S, Chaisson RE, Churchyard GJ. J Acquir Immune Defic Syndr; 2011 Oct 01; 58(2):219-23. PubMed ID: 21765364 [Abstract] [Full Text] [Related]
8. Utility of urine lipoarabinomannan (LAM) in diagnosing tuberculosis and predicting mortality with and without HIV: prospective TB cohort from the Thailand Big City TB Research Network. Suwanpimolkul G, Kawkitinarong K, Manosuthi W, Sophonphan J, Gatechompol S, Ohata PJ, Ubolyam S, Iampornsin T, Katerattanakul P, Avihingsanon A, Ruxrungtham K. Int J Infect Dis; 2017 Jun 01; 59():96-102. PubMed ID: 28457751 [Abstract] [Full Text] [Related]
9. Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study. Daley P, Michael JS, Hmar P, Latha A, Chordia P, Mathai D, John KR, Pai M. Int J Tuberc Lung Dis; 2009 Aug 01; 13(8):989-95. PubMed ID: 19723379 [Abstract] [Full Text] [Related]
10. Performance of urine lipoarabinomannan assays for paediatric tuberculosis in Tanzania. Kroidl I, Clowes P, Reither K, Mtafya B, Rojas-Ponce G, Ntinginya EN, Kalomo M, Minja LT, Kowuor D, Saathoff E, Kroidl A, Heinrich N, Maboko L, Bates M, O'Grady J, Zumla A, Hoelscher M, Rachow A. Eur Respir J; 2015 Sep 01; 46(3):761-70. PubMed ID: 26113682 [Abstract] [Full Text] [Related]
13. Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis. Lawn SD, Kerkhoff AD, Vogt M, Wood R. AIDS; 2012 Aug 24; 26(13):1635-43. PubMed ID: 22555166 [Abstract] [Full Text] [Related]
16. A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis. Sigal GB, Pinter A, Lowary TL, Kawasaki M, Li A, Mathew A, Tsionsky M, Zheng RB, Plisova T, Shen K, Katsuragi K, Choudhary A, Honnen WJ, Nahid P, Denkinger CM, Broger T. J Clin Microbiol; 2018 Dec 24; 56(12):. PubMed ID: 30257899 [Abstract] [Full Text] [Related]